429 related articles for article (PubMed ID: 11520181)
1. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
Fahnestock M; Michalski B; Xu B; Coughlin MD
Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
[TBL] [Abstract][Full Text] [Related]
2. ProNGF, sortilin, and age-related neurodegeneration.
Al-Shawi R; Hafner A; Chun S; Raza S; Crutcher K; Thrasivoulou C; Simons P; Cowen T
Ann N Y Acad Sci; 2007 Nov; 1119():208-15. PubMed ID: 18056969
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
[TBL] [Abstract][Full Text] [Related]
4. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.
Fahnestock M; Yu G; Michalski B; Mathew S; Colquhoun A; Ross GM; Coughlin MD
J Neurochem; 2004 May; 89(3):581-92. PubMed ID: 15086515
[TBL] [Abstract][Full Text] [Related]
5. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
[TBL] [Abstract][Full Text] [Related]
6. ProNGF: a neurotrophic or an apoptotic molecule?
Fahnestock M; Yu G; Coughlin MD
Prog Brain Res; 2004; 146():101-10. PubMed ID: 14699959
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophic activity of proNGF in vivo.
Buttigieg H; Kawaja MD; Fahnestock M
Exp Neurol; 2007 Apr; 204(2):832-5. PubMed ID: 17270174
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF.
Larsson E; Kuma R; Norberg A; Minde J; Holmberg M
Neurobiol Dis; 2009 Feb; 33(2):221-8. PubMed ID: 19038341
[TBL] [Abstract][Full Text] [Related]
9. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neuropathol Exp Neurol; 2004 Jun; 63(6):641-9. PubMed ID: 15217092
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor beta/pro-nerve growth factor and their receptors in normal human oral mucosa.
Hayashi K; Storesund T; Schreurs O; Khuu C; Husvik C; Karatsaidis A; Helgeland K; Martin-Zanca D; Schenck K
Eur J Oral Sci; 2007 Oct; 115(5):344-54. PubMed ID: 17850422
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons.
Lim KC; Tyler CM; Lim ST; Giuliano R; Federoff HJ
Biochem Biophys Res Commun; 2007 Sep; 361(3):599-604. PubMed ID: 17673176
[TBL] [Abstract][Full Text] [Related]
12. ProNGF inhibits NGF-mediated TrkA activation in PC12 cells.
Sobottka B; Reinhardt D; Brockhaus M; Jacobsen H; Metzger F
J Neurochem; 2008 Dec; 107(5):1294-303. PubMed ID: 18796003
[TBL] [Abstract][Full Text] [Related]
13. Increased NGF proforms in aged sympathetic neurons and their targets.
Bierl MA; Isaacson LG
Neurobiol Aging; 2007 Jan; 28(1):122-34. PubMed ID: 16377033
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy.
Stoica G; Lungu G; Kim HT; Wong PK
Brain Res; 2008 May; 1208():204-16. PubMed ID: 18395188
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor and its precursor differentially regulate hair cycle progression in mice.
Peters EM; Hendrix S; Gölz G; Klapp BF; Arck PC; Paus R
J Histochem Cytochem; 2006 Mar; 54(3):275-88. PubMed ID: 16009967
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic structural disorder of mouse proNGF.
Paoletti F; Covaceuszach S; Konarev PV; Gonfloni S; Malerba F; Schwarz E; Svergun DI; Cattaneo A; Lamba D
Proteins; 2009 Jun; 75(4):990-1009. PubMed ID: 19089979
[TBL] [Abstract][Full Text] [Related]
17. Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease.
Gelfo F; Tirassa P; De Bartolo P; Caltagirone C; Petrosini L; Angelucci F
J Alzheimers Dis; 2011; 25(2):213-7. PubMed ID: 21368378
[TBL] [Abstract][Full Text] [Related]
18. 'Mature' nerve growth factor is a minor species in most peripheral tissues.
Bierl MA; Jones EE; Crutcher KA; Isaacson LG
Neurosci Lett; 2005 May 20-27; 380(1-2):133-7. PubMed ID: 15854765
[TBL] [Abstract][Full Text] [Related]
19. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional properties of mouse proNGF.
Paoletti F; Konarev PV; Covaceuszach S; Schwarz E; Cattaneo A; Lamba D; Svergun DI
Biochem Soc Trans; 2006 Aug; 34(Pt 4):605-6. PubMed ID: 16856872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
